Harliku Disease Interactions
There is 1 disease interaction with Harliku (nitisinone).
Nitisinone (applies to Harliku) leukopenia/thrombocytopenia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Neutropenia
In clinical trials, patients treated with oral formulations of nitisinone and dietary restriction developed transient leukopenia (3%), thrombocytopenia (3%), or both (1.5%). No patients developed infections or bleeding as a result of the episodes of leukopenia and thrombocytopenia. Caution is advised especially in patients with low blood cell counts. Platelet and white blood cell counts should be monitored during therapy with nitisinone.
References (1)
- (2002) "Product Information. Orfadin (nitisinone)." Orphan Medical
Switch to consumer interaction data
Harliku drug interactions
There are 244 drug interactions with Harliku (nitisinone).
Harliku alcohol/food interactions
There is 1 alcohol/food interaction with Harliku (nitisinone).
Report options
More about Harliku (nitisinone)
- Harliku consumer information
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Nityr
Nityr is used to treat adult and children with a rare genetic condition called hereditary ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.